190 related articles for article (PubMed ID: 17512433)
1. A pathologist's perspective on emerging genomic tests for breast cancer.
Symmans WF
Semin Oncol; 2007 Apr; 34(2 Suppl 3):S4-9. PubMed ID: 17512433
[TBL] [Abstract][Full Text] [Related]
2. Understanding tumor profiling and assessing treatment.
Hyams DM
Manag Care; 2008 Jul; 17(7 Suppl 7):4-8; discussion 17-8. PubMed ID: 19093336
[TBL] [Abstract][Full Text] [Related]
3. State of the science: molecular classifications of breast cancer for clinical diagnostics.
Robison JE; Perreard L; Bernard PS
Clin Biochem; 2004 Jul; 37(7):572-8. PubMed ID: 15234238
[TBL] [Abstract][Full Text] [Related]
4. Quantitative biology: a new paradigm for tumor profiling, prognosis, and treatment.
Heaton AH
Manag Care; 2008 Jul; 17(7 Suppl 7):3; discussion 17-8. PubMed ID: 19097281
[No Abstract] [Full Text] [Related]
5. Assessing therapeutically developed assays.
Kolesar JM
Manag Care; 2008 Jul; 17(7 Suppl 7):9-12; discussion 17-8. PubMed ID: 19097282
[TBL] [Abstract][Full Text] [Related]
6. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer predictive factor testing: the challenges and importance of standardizing tissue handling.
Hicks DG; Kushner L; McCarthy K
J Natl Cancer Inst Monogr; 2011; 2011(42):43-5. PubMed ID: 21672896
[TBL] [Abstract][Full Text] [Related]
8. Technology insight: Emerging techniques to predict response to preoperative chemotherapy in breast cancer.
Pusztai L; Gianni L
Nat Clin Pract Oncol; 2004 Nov; 1(1):44-50. PubMed ID: 16264799
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling in breast cancer.
Nasser SM
J Med Liban; 2009; 57(2):83-8. PubMed ID: 19623883
[TBL] [Abstract][Full Text] [Related]
10. New generation of molecular prognostic and predictive tests for breast cancer.
Pusztai L; Cristofanilli M; Paik S
Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
[TBL] [Abstract][Full Text] [Related]
11. Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (Review).
Chuthapisith S; Eremin JM; Eremin O
Oncol Rep; 2008 Oct; 20(4):699-703. PubMed ID: 18813806
[TBL] [Abstract][Full Text] [Related]
12. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
[TBL] [Abstract][Full Text] [Related]
13. [Genomics and clinical research for breast cancer].
Bertucci F; Birnbaum D
Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
[TBL] [Abstract][Full Text] [Related]
14. A health plan's integration of molecular diagnostics and the impact on treatment pathways for quality care.
Wong W
Manag Care; 2008 Jul; 17(7 Suppl 7):13-6; discussion 17-8. PubMed ID: 19093337
[TBL] [Abstract][Full Text] [Related]
15. Genomic analysis from tissue core biopsies: standard of care for the future?
Sarkar S; Tuck DP; Harris LN
Breast Cancer Res Treat; 2009 Dec; 118(3):645-6. PubMed ID: 19234784
[No Abstract] [Full Text] [Related]
16. Genomic medicine. Gene expression tests foretell breast cancer's future.
Garber K
Science; 2004 Mar; 303(5665):1754-5. PubMed ID: 15031473
[No Abstract] [Full Text] [Related]
17. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
18. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
Nagasaki K; Miki Y
Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
20. Commercialized multigene predictors of clinical outcome for breast cancer.
Ross JS; Hatzis C; Symmans WF; Pusztai L; Hortobágyi GN
Oncologist; 2008 May; 13(5):477-93. PubMed ID: 18515733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
